Brown and Company PLC (COSE:BRWN.N0000)
Sri Lanka · Delayed Price · Currency is LKR 186.25
-0.75 (-0.40%)
At close: Aug 4, 2025
Regulus Therapeutics Cash Flow Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 32,423 | 2,382 | -6,230 | 21,589 | -16.05 | Upgrade |
Depreciation & Amortization | 9,954 | 5,685 | 7,190 | 2,779 | 2,818 | Upgrade |
Other Amortization | - | 93.81 | 36.88 | 33.63 | 18.02 | Upgrade |
Loss (Gain) From Sale of Assets | -118.59 | -955.38 | -108.03 | -92.46 | -52.61 | Upgrade |
Asset Writedown & Restructuring Costs | -3,015 | -14,580 | -19,904 | -16,898 | -1,208 | Upgrade |
Loss (Gain) From Sale of Investments | -1,068 | -2,012 | -430.99 | -769.03 | -198.94 | Upgrade |
Loss (Gain) on Equity Investments | -9,351 | -4,531 | -4,242 | -724.38 | 122.6 | Upgrade |
Provision & Write-off of Bad Debts | 484.77 | 872.24 | 0.2 | -170.62 | -172.67 | Upgrade |
Other Operating Activities | -69,025 | -34,055 | -6,860 | -13,742 | -3,057 | Upgrade |
Change in Accounts Receivable | 7,789 | -9,227 | -6,136 | -25,991 | -1,501 | Upgrade |
Change in Inventory | -1,110 | 1,674 | -3,390 | -8,462 | -2,087 | Upgrade |
Change in Accounts Payable | -24,561 | 38,885 | 10,511 | 27,164 | 8,360 | Upgrade |
Change in Other Net Operating Assets | 44,935 | 27,854 | 46,357 | 43,757 | -4,010 | Upgrade |
Operating Cash Flow | -22,047 | 12,086 | 16,793 | 28,473 | -985.54 | Upgrade |
Operating Cash Flow Growth | - | -28.03% | -41.02% | - | - | Upgrade |
Capital Expenditures | -18,909 | -12,408 | -14,132 | -5,436 | -5,298 | Upgrade |
Sale of Property, Plant & Equipment | 883.29 | 1,343 | 113.53 | 197.07 | 264.87 | Upgrade |
Cash Acquisitions | -6,450 | -5,824 | - | -6,517 | -497.18 | Upgrade |
Divestitures | 99.8 | 304.24 | 581.72 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | -15.58 | -20.42 | -60.3 | -9.41 | Upgrade |
Sale (Purchase) of Real Estate | - | 21.22 | -30.41 | -41,039 | -257.4 | Upgrade |
Investment in Securities | -1,851 | 2,030 | 911.21 | -9,887 | -987.76 | Upgrade |
Other Investing Activities | 178.49 | 7,162 | 2,820 | 1,616 | 473.66 | Upgrade |
Investing Cash Flow | -26,048 | -7,388 | -9,756 | -61,127 | -6,311 | Upgrade |
Short-Term Debt Issued | 17,250 | 857.81 | 2,620 | 6,202 | 1,382 | Upgrade |
Long-Term Debt Issued | 21,393 | 16,494 | 9,040 | 18,916 | 18,797 | Upgrade |
Total Debt Issued | 38,643 | 17,352 | 11,659 | 25,119 | 20,179 | Upgrade |
Long-Term Debt Repaid | -578.83 | -19,323 | -20,775 | -4,937 | -3,051 | Upgrade |
Total Debt Repaid | -578.83 | -19,323 | -20,775 | -4,937 | -3,051 | Upgrade |
Net Debt Issued (Repaid) | 38,065 | -1,971 | -9,115 | 20,182 | 17,128 | Upgrade |
Other Financing Activities | 9,853 | 365.08 | 976.16 | 14,123 | -7,628 | Upgrade |
Financing Cash Flow | 47,917 | -1,606 | -8,139 | 34,305 | 9,500 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | Upgrade |
Net Cash Flow | -177.4 | 3,092 | -1,103 | 1,651 | 2,203 | Upgrade |
Free Cash Flow | -40,955 | -322.54 | 2,661 | 23,037 | -6,284 | Upgrade |
Free Cash Flow Growth | - | - | -88.45% | - | - | Upgrade |
Free Cash Flow Margin | -37.98% | -0.40% | 3.66% | 45.80% | -21.38% | Upgrade |
Free Cash Flow Per Share | -192.62 | -1.52 | 12.52 | 108.34 | -29.55 | Upgrade |
Cash Interest Paid | 43,405 | 52,971 | 44,292 | 12,208 | 4,969 | Upgrade |
Cash Income Tax Paid | 903 | 563.05 | 308.9 | 65.64 | 74.84 | Upgrade |
Levered Free Cash Flow | -59,958 | 20,299 | 18,578 | 28,391 | -6,182 | Upgrade |
Unlevered Free Cash Flow | -31,141 | 54,560 | 47,882 | 36,412 | -2,693 | Upgrade |
Change in Net Working Capital | 25,550 | -60,539 | -49,467 | -37,718 | 572.76 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.